Rtw Investments, LP Adicet Bio, Inc. Transaction History

Rtw Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $2.4 $3.73 Million - $7.39 Million	-3,080,943 Reduced 74.52%	1,053,688 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$1.11 - $1.89 $118,593 - $201,929	-106,841 Reduced 2.52%	4,134,631 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $3.9 Million - $5.44 Million	290,191 Added 7.34%	4,241,472 $60.3 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $9.87 Million - $20 Million	961,799 Added 32.17%	3,951,281 $57.7 Million
Q1 2022 May 16, 2022	SELL	$11.53 - $19.97 $395,040 - $684,212	-34,262 Reduced 1.13%	2,989,482 $59.7 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $22.3 Million - $52.9 Million	3,023,744 New	3,023,744 $52.9 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.